India patent case threatens cheap drug supply

Swiss-based Novartis attempts to weaken Indian Patent Law that threatens to restrict access to live-saving medicines for millions in the developing world, a civic group said Monday.

The warning came as the Supreme Court is due Tuesday to hear more arguments Tuesday in an appeal by Novartis seeking patent protection for a newer version of its leukaemia drug Glivec - a case watched closely by ...